1-benzylpiperazine has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuddy, ML | 1 |
| Staack, RF | 1 |
| Green, JA | 1 |
| Button, J; Dargan, PI; Holt, DW; Lidder, S; Ramsey, J; Wood, DM | 1 |
| Bowie, D; Gee, P; Jerram, T | 1 |
| Dickson, AJ; Holler, JM; Lyons, TP; Vorce, SP | 1 |
| Berney-Meyer, L; Putt, T; Schollum, J; Walker, R | 1 |
| Drummer, OH; Forbes, SL; Fu, S; Luong, S; Philp, M; Stuart, BH; Wenholz, DS | 1 |
| Ahuja, M; Bhattacharya, D; Bhattacharya, S; Clark, CR; Deruiter, J; Dhanasekaran, M; Katz, DP; Suppiramaniam, V | 1 |
3 review(s) available for 1-benzylpiperazine and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Common drugs of abuse--Part II.
Topics: 4-Butyrolactone; Catha; Designer Drugs; Dibenzothiazepines; Diterpenes; Diterpenes, Clerodane; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drug and Narcotic Control; Flunitrazepam; Hallucinogens; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Methamphetamine; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Phenylpropanolamine; Piperazines; Psilocybin; Quetiapine Fumarate; Sodium Oxybate; Substance-Related Disorders; United States | 2004 |
Nephrotoxicity of recreational party drugs.
Topics: Acute Kidney Injury; Adult; Animals; Drug Overdose; Humans; Illicit Drugs; Kidney; Male; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Risk Assessment; Substance-Related Disorders; Young Adult | 2012 |
Benzylpiperazine: "A messy drug".
Topics: Contraindications; Designer Drugs; Dopamine; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Piperazines; Serotonin; Substance-Related Disorders; Vesicular Monoamine Transport Proteins | 2016 |
6 other study(ies) available for 1-benzylpiperazine and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Piperazine designer drugs of abuse.
Topics: Designer Drugs; Diagnostic Errors; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Structure-Activity Relationship | 2007 |
Partying on? Life after BZP-based party pills.
Topics: Adolescent; Adult; Central Nervous System Stimulants; Drug and Narcotic Control; Female; Hallucinogens; Health Surveys; Humans; Illicit Drugs; Intention; Male; N-Methyl-3,4-methylenedioxyamphetamine; New Zealand; Piperazines; Substance-Related Disorders | 2008 |
Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP).
Topics: Adolescent; Bruxism; Dissociative Disorders; Electrocardiography; Gas Chromatography-Mass Spectrometry; Hallucinogens; Humans; Illicit Drugs; Male; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Pupil; Substance-Related Disorders; Sympathomimetics; Tachycardia; Young Adult | 2008 |
Multiorgan failure from 1-benzylpiperazine ingestion--legal high or lethal high?
Topics: Drug Synergism; Female; Hallucinogens; Humans; Illicit Drugs; Male; Multiple Organ Failure; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Substance-Related Disorders; Young Adult | 2010 |
Detection of 1-benzylpiperazine, 1-(3-trifluoromethylphenyl)-piperazine, and 1-(3-chlorophenyl)-piperazine in 3,4-methylenedioxymethamphetamine-positive urine samples.
Topics: 3,4-Methylenedioxyamphetamine; Central Nervous System Stimulants; Designer Drugs; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Reproducibility of Results; Substance Abuse Detection; Urinalysis | 2010 |
A study to model the post-mortem stability of 4-MMC, MDMA and BZP in putrefying remains.
Topics: Animals; Forensic Pathology; Illicit Drugs; Methamphetamine; Models, Animal; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Postmortem Changes; Reproducibility of Results; Substance Abuse Detection; Swine | 2016 |